- Home
- TROO vs ATRA Comparison
TROO vs ATRA Comparison
Compare TROO & ATRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TROO
- ATRA
- Stock Information
- Founded
- TROO 2005
- ATRA 2012
- Country
- TROO Hong Kong
- ATRA United States
- Employees
- TROO N/A
- ATRA N/A
- Industry
- TROO Radio And Television Broadcasting And Communications Equipment
- ATRA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- TROO Technology
- ATRA Health Care
- Exchange
- TROO Nasdaq
- ATRA Nasdaq
- Market Cap
- TROO 103.8M
- ATRA 97.0M
- IPO Year
- TROO N/A
- ATRA 2014
- Fundamental
- Price
- TROO $1.34
- ATRA $15.52
- Analyst Decision
- TROO
- ATRA Strong Buy
- Analyst Count
- TROO 0
- ATRA 3
- Target Price
- TROO N/A
- ATRA $21.00
- AVG Volume (30 Days)
- TROO 179.7K
- ATRA 52.8K
- Earning Date
- TROO 11-14-2025
- ATRA 11-11-2025
- Dividend Yield
- TROO N/A
- ATRA N/A
- EPS Growth
- TROO N/A
- ATRA N/A
- EPS
- TROO N/A
- ATRA 0.56
- Revenue
- TROO $10,073,000.00
- ATRA $188,667,000.00
- Revenue This Year
- TROO N/A
- ATRA N/A
- Revenue Next Year
- TROO N/A
- ATRA N/A
- P/E Ratio
- TROO N/A
- ATRA $27.80
- Revenue Growth
- TROO 182.24
- ATRA 202.41
- 52 Week Low
- TROO $0.49
- ATRA $5.01
- 52 Week High
- TROO $3.05
- ATRA $18.71
- Technical
- Relative Strength Index (RSI)
- TROO 59.53
- ATRA 73.14
- Support Level
- TROO $1.16
- ATRA $13.92
- Resistance Level
- TROO $1.54
- ATRA $14.84
- Average True Range (ATR)
- TROO 0.17
- ATRA 0.93
- MACD
- TROO -0.01
- ATRA 0.14
- Stochastic Oscillator
- TROO 45.20
- ATRA 86.79
About TROO TROOPS Inc.
TROOPS Inc is a conglomerate group of various businesses with its headquarters based in Hong Kong. The group is principally engaged in money lending business in Hong Kong providing mortgage loans to high quality target borrowers, property investment to generate additional rental income and the development, operation and management of an online financial marketplace that provides one-stop financial technology solutions including API services by leveraging artificial intelligence, large data and blockchain, and cloud computing (SaaS). It derives revenue from Hong Kong and Australia. Majority of its revenue generates from domestic market.
About ATRA Atara Biotherapeutics Inc.
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).